Cargando…
Prediabetes screening: Questionable benefits in the golden years
Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage prim...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065303/ https://www.ncbi.nlm.nih.gov/pubmed/33912821 http://dx.doi.org/10.1016/j.metop.2021.100091 |
_version_ | 1783682311329415168 |
---|---|
author | Tsilingiris, Dimitrios Vallianou, Natalia G. Dalamaga, Maria |
author_facet | Tsilingiris, Dimitrios Vallianou, Natalia G. Dalamaga, Maria |
author_sort | Tsilingiris, Dimitrios |
collection | PubMed |
description | Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage primarily aim to hinder the development of overt hyperglycemia rather than to prevent complications. Current recommendations for prediabetes testing are common across all adult age categories. Recent evidence arising from the prospective investigation of the natural course of prediabetes among elderly individuals pose questions regarding the benefits of meticulous prediabetes screening in this age group. In view of this and due to the lack of sufficient data to concretely support a positive impact of further preventive strategies among older individuals, screening recommendations should be reevaluated to target selected elderly individuals who are most likely to benefit in terms of quality of life and prognosis. Further therapeutic measures should be tailored to the inherent features of this frail age group, in order to exert a meaningful effect on overall health status. |
format | Online Article Text |
id | pubmed-8065303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-80653032021-04-27 Prediabetes screening: Questionable benefits in the golden years Tsilingiris, Dimitrios Vallianou, Natalia G. Dalamaga, Maria Metabol Open Editorial Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage primarily aim to hinder the development of overt hyperglycemia rather than to prevent complications. Current recommendations for prediabetes testing are common across all adult age categories. Recent evidence arising from the prospective investigation of the natural course of prediabetes among elderly individuals pose questions regarding the benefits of meticulous prediabetes screening in this age group. In view of this and due to the lack of sufficient data to concretely support a positive impact of further preventive strategies among older individuals, screening recommendations should be reevaluated to target selected elderly individuals who are most likely to benefit in terms of quality of life and prognosis. Further therapeutic measures should be tailored to the inherent features of this frail age group, in order to exert a meaningful effect on overall health status. Elsevier 2021-04-07 /pmc/articles/PMC8065303/ /pubmed/33912821 http://dx.doi.org/10.1016/j.metop.2021.100091 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Editorial Tsilingiris, Dimitrios Vallianou, Natalia G. Dalamaga, Maria Prediabetes screening: Questionable benefits in the golden years |
title | Prediabetes screening: Questionable benefits in the golden years |
title_full | Prediabetes screening: Questionable benefits in the golden years |
title_fullStr | Prediabetes screening: Questionable benefits in the golden years |
title_full_unstemmed | Prediabetes screening: Questionable benefits in the golden years |
title_short | Prediabetes screening: Questionable benefits in the golden years |
title_sort | prediabetes screening: questionable benefits in the golden years |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065303/ https://www.ncbi.nlm.nih.gov/pubmed/33912821 http://dx.doi.org/10.1016/j.metop.2021.100091 |
work_keys_str_mv | AT tsilingirisdimitrios prediabetesscreeningquestionablebenefitsinthegoldenyears AT vallianounataliag prediabetesscreeningquestionablebenefitsinthegoldenyears AT dalamagamaria prediabetesscreeningquestionablebenefitsinthegoldenyears |